304 related articles for article (PubMed ID: 15082872)
1. The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist.
Kłodzińska A; Tatarczyńska E; Stachowicz K; Chojnacka-Wójcik E
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):113-26. PubMed ID: 15082872
[TBL] [Abstract][Full Text] [Related]
2. Effect of the class I metabotropic glutamate receptor antagonist AIDA on certain behaviours in rats with experimental chronic hyperammonemia.
Grzeda E; Wiśniewska RJ
Adv Med Sci; 2009; 54(2):269-76. PubMed ID: 19875354
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A
Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823
[TBL] [Abstract][Full Text] [Related]
4. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
5. AIDA influences behavior in rats pretreated with baclofen.
Car H; Nadlewska A; Oksztel R; Wiśniewski K
Pol J Pharmacol; 2001; 53(3):245-52. PubMed ID: 11785925
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
7. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A
Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
[TBL] [Abstract][Full Text] [Related]
8. Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats.
Lyeth BG; Gong QZ; Shields S; Muizelaar JP; Berman RF
Exp Neurol; 2001 May; 169(1):191-9. PubMed ID: 11312571
[TBL] [Abstract][Full Text] [Related]
9. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
[TBL] [Abstract][Full Text] [Related]
11. Influence of AIDA on certain behaviors in rats subjected to experimental hypoxia.
Nadlewska A; Car H; Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 2003; 55(2):171-80. PubMed ID: 12926544
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
13. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam.
Gannon RL; Lungwitz E; Batista N; Hester I; Huntley C; Peacock A; Delagrange P; Millan MJ
Behav Brain Res; 2011 Mar; 218(1):8-14. PubMed ID: 21094664
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat.
Castagne V; Lemaire M; Kheyfets I; Dugina JL; Sergeeva SA; Epstein OI
J Pharm Pharmacol; 2008 Mar; 60(3):309-16. PubMed ID: 18284810
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
16. An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine.
de Araújo Godinho MA; Meneghini L; Lucinda AM; Borges FR; Sakae DY; Marino Neto J; Paschoalini MA; de Lima TC; Faria MS
Behav Brain Res; 2007 Jun; 180(1):86-94. PubMed ID: 17408761
[TBL] [Abstract][Full Text] [Related]
17. The influence of NMDA, a potent agonist of glutamate receptor, on behavioral activity of rats with experimental hyperammonemia evoked by liver failure.
Fedosiewicz-Wasiluk M; Hoły ZZ; Wiśniewska RJ; Wiśniewski K
Amino Acids; 2005 Feb; 28(1):111-7. PubMed ID: 15700110
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of chalcones--a flavonoid subclass, for, their anxiolytic effects in rats using elevated plus maze and open field behaviour tests.
Jamal H; Ansari WH; Rizvi SJ
Fundam Clin Pharmacol; 2008 Dec; 22(6):673-81. PubMed ID: 19049672
[TBL] [Abstract][Full Text] [Related]
19. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration.
Tatarczyńska E; Kłodzińska A; Kroczka B; Chojnacka-Wójcik E; Pilc A
Psychopharmacology (Berl); 2001 Oct; 158(1):94-9. PubMed ID: 11685389
[TBL] [Abstract][Full Text] [Related]
20. Effects of mGluR5 and mGluR1 antagonists on anxiety-like behavior and learning in developing rats.
Mikulecká A; Mares P
Behav Brain Res; 2009 Dec; 204(1):133-9. PubMed ID: 19505510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
